Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 95651-95700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04848779
A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)
N/AActive, not recruiting
16 participants
Started: Jun 10, 2021 · Completed: Oct 28, 2026
1 condition1 sponsor15 locations
NCT04688528
Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC
NARecruiting
147 participants
Started: Jun 10, 2021 · Completed: Jan 31, 2027
1 condition3 sponsors10 locations
NCT04687020
Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)
PHASE4Active, not recruiting
9 participants
Started: Jun 10, 2021 · Completed: Oct 31, 2032
1 condition1 sponsor5 locations
NCT04898153
First-in-Human (FIH) Study of the Xeltis Hemodialysis Access Graft
NAActive, not recruiting
20 participants
Started: Jun 10, 2021 · Completed: Sep 30, 2027
2 conditions1 sponsor6 locations
NCT05662293
Characterization of Arrhythmia-induced Cardiomyopathy
N/ARecruiting
2,700 participants
Started: Jun 10, 2021 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT04804644
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
PHASE3Recruiting
200 participants
Started: Jun 10, 2021 · Completed: Jul 1, 2030
4 conditions2 sponsors223 locations
NCT06775457
Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)
NARecruiting
120 participants
Started: Jun 10, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor5 locations
NCT04567355
Migraine Manager (R01)
PHASE2Recruiting
160 participants
Started: Jun 10, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT04923100
Therapeutic Effect of New Biologics in Crohn's Disease
N/ARecruiting
50 participants
Started: Jun 10, 2021 · Completed: Mar 29, 2025
4 conditions1 sponsor1 location
NCT04223115
A Randomized Controlled Study of Digitalized Cognitive Behavioral Intervention for Antenatal Depression
NARecruiting
634 participants
Started: Jun 10, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT04876456
A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
PHASE2Active, not recruiting
50 participants
Started: Jun 10, 2021 · Completed: Jan 31, 2027
4 conditions3 sponsors1 location
NCT04873128
Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach
NARecruiting
110 participants
Started: Jun 10, 2021 · Completed: Jul 1, 2024
1 condition1 sponsor1 location
NCT04657822
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
PHASE4Recruiting
130 participants
Started: Jun 10, 2021 · Completed: Jun 10, 2031
1 condition1 sponsor29 locations
NCT05585047
Treatment Response Biomarkers in MDD
N/ARecruiting
480 participants
Started: Jun 10, 2021 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT04277689
Deep Neural Network Approaches for Closed-Loop Deep Brain Stimulation
NAEnrolling by invitation
30 participants
Started: Jun 10, 2021 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT04739527
Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment
PHASE1Active, not recruiting
17 participants
Started: Jun 10, 2021 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT04615988
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
N/ARecruiting
16 participants
Started: Jun 9, 2021 · Completed: Jun 30, 2027
3 conditions1 sponsor1 location
NCT04329676
directSTIM Deep Brain Stimulation System Study
NARecruiting
62 participants
Started: Jun 9, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor6 locations
NCT04804124
Sleep Duration and Cardiovascular Health
NARecruiting
24 participants
Started: Jun 9, 2021 · Completed: Mar 15, 2026
2 conditions1 sponsor1 location
NCT04706598
Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment
PHASE1/PHASE2Active, not recruiting
25 participants
Started: Jun 9, 2021 · Completed: Dec 31, 2024
2 conditions2 sponsors4 locations
NCT04805866
Tracking Neural Synergies After Stroke.
N/AActive, not recruiting
36 participants
Started: Jun 9, 2021 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT04411303
A Novel, Comprehensive Approach to Post-stroke Gait Rehabilitation
PHASE1Recruiting
50 participants
Started: Jun 9, 2021 · Completed: Dec 14, 2025
1 condition1 sponsor1 location
NCT04913337
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
PHASE1/PHASE2Active, not recruiting
179 participants
Started: Jun 9, 2021 · Completed: Jul 31, 2025
15 conditions2 sponsors27 locations
NCT04901702
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
PHASE1/PHASE2Active, not recruiting
46 participants
Started: Jun 9, 2021 · Completed: Dec 31, 2025
22 conditions3 sponsors10 locations
NCT06552078
Activation of Biobank Registry for Bilio-pancreatic Diseases
N/ARecruiting
2,000 participants
Started: Jun 9, 2021 · Completed: Dec 31, 2030
4 conditions1 sponsor1 location
NCT04945538
Scatter Radiation Exposure During Coronary Procedures - The Occupational SCAtter Radiation Registry
N/ARecruiting
2,000 participants
Started: Jun 9, 2021 · Completed: Sep 8, 2025
1 condition1 sponsor1 location
NCT05380440
Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: FAIR
NAActive, not recruiting
240 participants
Started: Jun 9, 2021 · Completed: Aug 31, 2025
4 conditions1 sponsor1 location
NCT04864067
No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer
PHASE2Active, not recruiting
73 participants
Started: Jun 9, 2021 · Completed: Mar 1, 2026
1 condition1 sponsor3 locations
NCT05652387
Father Inclusive Prenatal Care Study
NARecruiting
250 participants
Started: Jun 9, 2021 · Completed: Sep 29, 2025
6 conditions6 sponsors1 location
NCT04853173
Modality of Pain Management in Ambulatory Tonsillectomy Surgery in Adults
NARecruiting
30 participants
Started: Jun 9, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04551222
The Re-Prosper HF Study
PHASE2/PHASE3Recruiting
120 participants
Started: Jun 9, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT04791540
Sarcopenia and Nutritional Status in a Rehabilitation Setting
N/ARecruiting
30 participants
Started: Jun 9, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04897009
Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer
N/AActive, not recruiting
38 participants
Started: Jun 9, 2021 · Completed: Jun 8, 2026
1 condition2 sponsors1 location
NCT04855253
Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL
PHASE1/PHASE2Recruiting
30 participants
Started: Jun 9, 2021 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT04928677
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
PHASE1Recruiting
50 participants
Started: Jun 9, 2021 · Completed: Jun 30, 2026
2 conditions2 sponsors5 locations
NCT04196374
Return of Genomic Results and Aggregate Penetrance in Population-Based Cohorts
NAEnrolling by invitation
110 participants
Started: Jun 9, 2021 · Completed: Jun 30, 2025
2 conditions7 sponsors2 locations
NCT04679870
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis
PHASE2Active, not recruiting
21 participants
Started: Jun 9, 2021 · Completed: Jun 30, 2026
1 condition2 sponsors11 locations
NCT04720157
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC
PHASE3Active, not recruiting
1,145 participants
Started: Jun 9, 2021 · Completed: Feb 11, 2027
1 condition3 sponsors166 locations
NCT04558866
Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)
PHASE2Active, not recruiting
51 participants
Started: Jun 9, 2021 · Completed: Jun 30, 2025
1 condition2 sponsors6 locations
NCT04464980
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
PHASE2Active, not recruiting
1,516 participants
Started: Jun 8, 2021 · Completed: Jan 31, 2027
1 condition7 sponsors21 locations
NCT04881019
PRediction Of Glycemic RESponse Study
N/AActive, not recruiting
1,070 participants
Started: Jun 8, 2021 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT04082767
Sedation Efficacy of Dexmedetomidine Versus Midazolam in Critically Ill Ventilated Children
PHASE3Recruiting
120 participants
Started: Jun 8, 2021 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT04748640
Bilateral Essential Tremor Treatment With Gamma Knife
PHASE2/PHASE3Recruiting
50 participants
Started: Jun 8, 2021 · Completed: Oct 31, 2026
1 condition2 sponsors2 locations
NCT04839991
Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.
PHASE1Recruiting
70 participants
Started: Jun 8, 2021 · Completed: Sep 25, 2024
1 condition1 sponsor20 locations
NCT04765345
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F
N/AActive, not recruiting
44 participants
Started: Jun 8, 2021 · Completed: Jun 30, 2027
3 conditions4 sponsors10 locations
NCT04746924
A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer
PHASE3Active, not recruiting
662 participants
Started: Jun 8, 2021 · Completed: Mar 31, 2026
2 conditions1 sponsor218 locations
NCT04225585
Well-Being After Breast Cancer Surgery
NAActive, not recruiting
316 participants
Started: Jun 8, 2021 · Completed: Mar 31, 2026
2 conditions2 sponsors2 locations
NCT04877691
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
PHASE3Active, not recruiting
367 participants
Started: Jun 8, 2021 · Completed: Nov 18, 2026
1 condition2 sponsors140 locations
NCT06536257
Personalised Immunotherapy Platform
N/ARecruiting
1,000 participants
Started: Jun 8, 2021 · Completed: Jun 1, 2037
5 conditions1 sponsor3 locations
NCT04614558
Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance
PHASE2Recruiting
27 participants
Started: Jun 8, 2021 · Completed: Jun 30, 2026
1 condition2 sponsors2 locations